Publication: Surgical results of laparoscopic loop duodenojejunal bypass with sleeve gastrectomy (LDJB-SG) in obese asians (BMI = 27.5 kg/m2) with type 2 diabetes mellitus (T2DM): A new promising bariatric and metabolic surgery
5
Issued Date
2018-03-01
Resource Type
ISSN
22288082
Other identifier(s)
2-s2.0-85051589567
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Siriraj Medical Journal. Vol.70, No.2 (2018), 103-113
Suggested Citation
Voraboot Taweerutchana, Ming Che Hsin, Po Chih Chang, Chi Ming Tai, Chih Kun Huang Surgical results of laparoscopic loop duodenojejunal bypass with sleeve gastrectomy (LDJB-SG) in obese asians (BMI = 27.5 kg/m2) with type 2 diabetes mellitus (T2DM): A new promising bariatric and metabolic surgery. Siriraj Medical Journal. Vol.70, No.2 (2018), 103-113. doi:10.14456/smj.2018.18 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/46902
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Surgical results of laparoscopic loop duodenojejunal bypass with sleeve gastrectomy (LDJB-SG) in obese asians (BMI = 27.5 kg/m2) with type 2 diabetes mellitus (T2DM): A new promising bariatric and metabolic surgery
Other Contributor(s)
Abstract
© 2018, Faculty of Medicine Siriraj Hospital, Mahidol University. Objective: To demonstrate surgical outcomes, safety and complications in obese Asians (BMI > 27.5 kg/m2) who underwent LDJB-SG in our center. Methods: We retrospectively reviewed ninety-one patients who underwent LDJB-SG from October 2011 to March 2014. One-year surgical outcomes regarding the efficacy of weight loss, safety as well as complications of this procedure were demonstrated. Remission of T2DM and co-morbidities resolution after one year were also analyzed. Results: The median duration of T2DM was 60 months and the median operative time was 140 min. Interestingly, the mean/median preoperative BMI, HbA1C and FPG levels dropped significantly from 30.7 kg/m2, 8.9%, and 139.0 mg% to 23.7 kg/m2, 6.2%, and 95.0 mg% respectively at 1 year after operation (p<0.001). Furthermore, 61.5% of patients who had completed 1 year follow-up showed complete diabetic remission and 92.3% experienced glycemic control (HbA1c<7% without any medication). The postoperative complications were intra-abdominal bleeding (4.4%), leakage (1.1%), stricture (3.3%) and port site hernia (2.2%). Conclusion: LDJB-SG is a safe and feasible bariatric and metabolic surgery, which has demonstrated excellent outcomes in terms of weight reduction, co-morbidities resolution as well as glycemic control in short-term follow-up.